ribavirin has been researched along with Retinal Neovascularization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, RJ; Camargo, R; Cilvetti, A; Clavijo, E; García-Cortés, M; González, FJ; Lucena, MI; Martos-VanDussen, JV; Rosón, P; Vázquez, L | 1 |
1 trial(s) available for ribavirin and Retinal Neovascularization
Article | Year |
---|---|
Vascular ophthalmological side effects associated with antiviral therapy for chronic hepatitis C are related to vascular endothelial growth factor levels.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Eye Diseases; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retinal Neovascularization; Ribavirin; Vascular Endothelial Growth Factor A | 2006 |